Publication | Closed Access

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial

VaccinologyVaccine SafetyVaccinationAnthrax VaccineImmunologyVaccine TrialVaccine TestingVaccine EfficacyInfection ControlMedicineRecombinant Protective Antigen